- Home
- ABEO vs AEF Comparison
ABEO vs AEF Comparison
Compare ABEO & AEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- AEF
- Stock Information
- Founded
- ABEO N/A
- AEF 1989
- Country
- ABEO United States
- AEF United States
- Employees
- ABEO N/A
- AEF N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- AEF Finance/Investors Services
- Sector
- ABEO Health Care
- AEF Finance
- Exchange
- ABEO Nasdaq
- AEF Nasdaq
- Market Cap
- ABEO 237.4M
- AEF 260.4M
- IPO Year
- ABEO 1980
- AEF N/A
- Fundamental
- Price
- ABEO $4.68
- AEF $4.98
- Analyst Decision
- ABEO Strong Buy
- AEF
- Analyst Count
- ABEO 5
- AEF 0
- Target Price
- ABEO $17.00
- AEF N/A
- AVG Volume (30 Days)
- ABEO 503.6K
- AEF 92.5K
- Earning Date
- ABEO 03-20-2025
- AEF 01-01-0001
- Dividend Yield
- ABEO N/A
- AEF 7.13%
- EPS Growth
- ABEO N/A
- AEF N/A
- EPS
- ABEO N/A
- AEF 0.57
- Revenue
- ABEO N/A
- AEF N/A
- Revenue This Year
- ABEO N/A
- AEF N/A
- Revenue Next Year
- ABEO $561.86
- AEF N/A
- P/E Ratio
- ABEO N/A
- AEF $8.86
- Revenue Growth
- ABEO N/A
- AEF N/A
- 52 Week Low
- ABEO $3.05
- AEF $4.40
- 52 Week High
- ABEO $8.45
- AEF $5.53
- Technical
- Relative Strength Index (RSI)
- ABEO 36.32
- AEF 36.17
- Support Level
- ABEO $4.42
- AEF $4.93
- Resistance Level
- ABEO $5.14
- AEF $5.22
- Average True Range (ATR)
- ABEO 0.25
- AEF 0.06
- MACD
- ABEO -0.05
- AEF -0.01
- Stochastic Oscillator
- ABEO 25.24
- AEF 16.13
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About AEF abrdn Emerging Markets Equity Income Fund Inc.
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. is a closed-end investment company. The Fund's investment objective is to seek to provide both current income and long-term capital appreciation. It invests in the public equity and fixed income markets of Chile. The Fund invests in a range of sectors, including financials, consumer staples, utilities, consumer discretionary, materials, energy, information technology, Private Equity, telecommunication services, healthcare, real estate and industrials.